Uniunea Europeană - română - EMA (European Medicines Agency)

accord healthcare s.l.u. - acetat de abirateron - prostate neoplasme - terapia endocrină - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Uniunea Europeană - română - EMA (European Medicines Agency)

mylan ireland limited - acetat de abirateron - prostate neoplasme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Uniunea Europeană - română - EMA (European Medicines Agency)

krka, d.d., novo mesto - acetat de abirateron - prostate neoplasme - terapia endocrină - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rompharm company s.r.l. - romania - alprazolamum - pulb+solv. pt. sol. inj. - 250mg - corticosteroizi sistemici glucocorticoizi

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rompharm company s.r.l. - romania - alprazolamum - pulb+solv. pt. sol. inj. - 500mg - corticosteroizi sistemici glucocorticoizi

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

rompharm company srl - alprazolamum - pulbere şi solvent pentru soluţie injectabilă - 250 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

rompharm company srl - alprazolamum - pulbere şi solvent pentru soluţie injectabilă - 500 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

orion corporation - methylprednisolonum - comprimate - 4 mg

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bayer pharma ag - methylprednisolonum aceponat - unguent - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bayer pharma ag - methylprednisolonum aceponat - crema - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)